Dinoprostone Vaginal Insert Versus Double Balloon Catheter for Preinduction Cervical Ripening
1 other identifier
interventional
200
1 country
1
Brief Summary
Effıcacy of dinoprostone vaginal insert versus double- balloon catheter among women in the induction of labor
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2016
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 8, 2017
CompletedFirst Posted
Study publicly available on registry
January 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedJanuary 10, 2017
November 1, 2016
5 months
January 8, 2017
January 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vaginal delivery after initiation of ripening within 24 hours
24 hours
Secondary Outcomes (1)
Occurence of cesarean section
24 hours
Study Arms (2)
Cook double balloon catheter
EXPERIMENTALA double- balloon catheter (Cook Cervical Ripener Balloon,Cook OB/GYN,Spencer IN) is inserted into cervical canal under direct visualisation during a sterile speculum examination İt is placed for 12 hours
Dinoprostone
ACTIVE COMPARATOR10 mg of dinoprostone in a hydrogel insert is placed high in the vaginal fornix. İt is placed for 12 hours.It is a controlled release formulation which has been found to release dinoprostone in vivo at a rate of approximately 0.3 mg/hr.
Interventions
A double- balloon catheter (Cook Cervical Ripener Balloon,Cook OB/GYN,Spencer IN) is inserted into cervical canal under direct visualisation during a sterile speculum examination.İt is placed for 12 hours
10 mg of dinoprostone in a hydrogel insert is placed high in the vaginal fornix. İt is placed for 12 hours.It is a controlled release formulation which has been found to release dinoprostone in vivo at a rate of approximately 0.3 mg/hr.
Eligibility Criteria
You may qualify if:
- Eligible women have obstetric or medical indications for labor induction with intact membranes
- singleton pregnancies,
- vertex presentations
- low Bishop scores ≤6
- gestational age ≥34 w
- reassuring fetal heart tracing on admission.
You may not qualify if:
- unexplained vaginal bleeding
- nonvertex presentation
- intrauterine fetal death
- prior cesarean delivery
- any scarred uterus
- any other contraindications for vaginal delivery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi
Istanbul, 34325, Turkey (Türkiye)
Related Publications (3)
Cromi A, Ghezzi F, Uccella S, Agosti M, Serati M, Marchitelli G, Bolis P. A randomized trial of preinduction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter. Am J Obstet Gynecol. 2012 Aug;207(2):125.e1-7. doi: 10.1016/j.ajog.2012.05.020. Epub 2012 Jun 1.
PMID: 22704766BACKGROUNDConnolly KA, Kohari KS, Rekawek P, Smilen BS, Miller MR, Moshier E, Factor SH, Stone JL, Bianco AT. A randomized trial of Foley balloon induction of labor trial in nulliparas (FIAT-N). Am J Obstet Gynecol. 2016 Sep;215(3):392.e1-6. doi: 10.1016/j.ajog.2016.03.034. Epub 2016 Mar 24.
PMID: 27018464BACKGROUNDde Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4.
PMID: 36996264DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 8, 2017
First Posted
January 10, 2017
Study Start
November 1, 2016
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
January 10, 2017
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share